AI Transparency Report
The Florida Proton Therapy Institute Inc demonstrates consistent financial operations with annual revenues in the range of $41M to $59M over the past decade. The organization consistently reports positive net income, with revenues generally exceeding expenses, indicating a stable financial position. For instance, in the 202306 period, revenue was $45,555,232 against expenses of $45,128,255, resulting in a surplus. Assets have fluctuated but remain substantial, at $137,388,571 in the latest filing, though they have seen a decline from a peak of $161,258,622 in 201806. Liabilities have also decreased from a high of $93,110,370 in 201406 to $52,424,249 in 202306, improving the organization's equity position.
Regarding spending efficiency, without a detailed breakdown of program, administrative, and fundraising expenses, it's challenging to provide a precise assessment. However, the consistent surpluses suggest that the organization is managing its overall expenditures effectively within its revenue streams. The absence of reported officer compensation across all filings is a notable point regarding transparency and executive remuneration practices, suggesting either a volunteer leadership structure or compensation being reported under other expense categories, which would warrant further investigation for complete transparency. The organization's NTEE code E24 indicates a focus on cancer treatment, aligning with its name and suggesting a clear programmatic mission.